Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413
Conditions: Prostate Cancer Interventions: Drug: Whole body study and SPECT with [99mTc]Tc-BQ0413 Sponsors: Tomsk National Research Medical Center of the Russian Academy of Sciences; Uppsala University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
Conditions: Prostate Cancer; Oligoprogressive; Urothelial Carcinoma; Renal Cell Carcinoma Interventions: Device: Ablative local therapy Sponsors: University of California, Davis; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
Conditions: High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Interventions: Drug: dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets; Drug: placebo; abiraterone acetate tablets; prednisone tablets Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
Conditions: Prostate Cancer; Metastatic Castration-resistant Prostate Cancer; Metastatic Castration-resistant Prostate Carcinoma Interventions: Drug: 18F-DCFPyl Sponsors: Dana-Farber Cancer Institute; Progenics Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
Conditions: Metastatic Castration-resistant Prostate Cancer Interventions: Drug: Testosterone Cypionate; Drug: Sipuleucel-T Sponsors: Yale University; Dendreon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Binaural Sound for Remimazolam Induction
Conditions: General Anesthesia; Prostate Cancer; Uterine Myoma Interventions: Procedure: Binaural sound; Procedure: Placebo Sponsors: Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Enzalutamide and M9241 in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Conditions: Prostate Cancer; Recurrent Prostate Cancer; PET Positive Interventions: Drug: Enzalutamide; Drug: M9241 Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
Conditions: Prostate Carcinoma; Prostate Small Cell Neuroendocrine Carcinoma; Stage III Prostate Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8 Interventions: Drug: Bendamustine; Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Bridge Therapy; Procedure: Computed Tomography; Drug: Cyclophosphamide; Procedure: Echocardiography; Drug: Fludarabine; Procedure: Leukapheresis; Procedure: Multigated Acquisition Scan; Biological: T-cell Receptor-engineered T-cells; Procedure: X-Ray Imaging Sponsors: Fred Hutchinson Cancer Center; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging
Conditions: Prostate Cancer Interventions: Other: MR prostate exam Sponsors: Centre Hospitalier Universitaire, Amiens Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer Interventions: Drug: JNJ-78278343; Drug: JNJ-87189401 Sponsors: Janssen Research& Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Generation and Validation of Predictive Models for Localized Prostate Cancer Treated With External Radiotherapy.
Conditions: Predictive Cancer Model; Localized Prostate Carcinoma Interventions: Radiation: EXTERNAL RADIOTHERAPY Sponsors: Consorci Sanitari de Terrassa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Image-guided Navigation During Robotic Sentinel Node Removal
Conditions: Prostate Cancer Interventions: Other: Image-guided navigation Sponsors: The Netherlands Cancer Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
Conditions: Prostate Cancer Interventions: Drug: ADI-PEG 20; Drug: Cabazitaxel; Drug: Carboplatin Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
An Open-Label Phase I/II Study to Evaluate the Safety and prelimiBasnary Efficacy of Amivantamab and Tepotinib Combination in MET-altered Non-small Cell Lung Cancer (NSCLC)
Conditions: Prostate Cancer Interventions: Drug: ADI-PEG 20; Drug: Cabazitaxel; Drug: Carboplatin Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
Conditions: Prostate Cancer; Radical Prostatectomy Interventions: Drug: REGN5678; Drug: Piflufolastat F18 Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
